- Address 3400 Civic Center Boulevard, West Pavilion Philadelphia, PA 19104
- Executive Director Dr. Keith A. Cengel
Speak with our nurse for help contacting this cancer center
Penn Medicine’s Abramson Cancer Center (ACC) is internationally recognized for its high-quality patient care and premier cancer research. The ACC offers more mesothelioma treatment options than most medical facilities. Its Mesothelioma and Pleural Disease Program provides state-of-the-art treatment, advanced surgical techniques, and access to clinical trials. The ACC treats all types and stages of mesothelioma.
Speak with our nurse for help contacting this cancer center
Founded in 1973, the Abramson Cancer Center of the University of Pennsylvania is a world leader in cancer care. Since 1974, the National Cancer Institute (NCI) has continuously named the ACC a Comprehensive Cancer Center, the NCI’s most prestigious status of excellence in cancer care. In fact, the ACC was one of the first NCI-Designated Comprehensive Cancer Centers in the nation.
The center uses a multidisciplinary approach to treat mesothelioma, in which experts from various fields come together to develop the best treatment plan possible. This approach allows the ACC to address some of the most challenging problems in cancer care.
“We are a life-changing, community-changing, world-changing cancer center.”
—Abramson Cancer Center
The ACC is part of the University of Pennsylvania Health System. This impressive health care system includes the Hospital of the University of Pennsylvania, Pennsylvania Hospital, Penn Presbyterian Medical Center, and Children’s Hospital of Philadelphia.
Penn Medicine’s Abramson Cancer Center helps over 300,000 cancer patients every year. This includes providing state-of-the-art treatment to patients with all types of mesothelioma.
For help finding top mesothelioma cancer treatment centers, get our Free Mesothelioma Guide. The guide contains over 90 pages of detailed, easy-to-understand information for mesothelioma patients and their loved ones.
The Abramson Cancer Center is the cornerstone of the Penn Cancer Network. This network is made up of a group of hospitals and community practices in the Delaware Valley. It is known for providing exceptional cancer care to patients throughout the greater Philadelphia region and beyond.
The Abramson Cancer Center:
The Abramson Cancer Center team is devoted to providing compassionate and personal attention to every patient. Mesothelioma patients treated here can expect to work with a caring, multidisciplinary team experienced with the disease.
“The ACC is deeply committed to its mission to improve the lives of adults and children with cancer in the greater Philadelphia area, across the nation, and around the world.”
—Abramson Cancer Center
The ACC caregivers develop highly personalized treatment plans. This means each patient will receive the therapeutic strategy most likely to have the best results for their specific circumstance.
This approach is crucial for mesothelioma patients since each type and stage of mesothelioma requires a customized treatment strategy.
The clinical program at the ACC is made up of:
Additionally, the Abramson Cancer Center has a reputation for being highly responsive and sensitive to patients’ physical, mental, and emotional needs. The ACC has a wide range of support services tailored to the needs of each patient.
Support services at the Abramson Cancer Center include:
The Abramson Cancer Center’s Mesothelioma and Pleural Disease Program focuses on providing the best possible therapies for mesothelioma patients.
Firmly dedicated to research, the ACC utilizes the latest medical research and technology advancements to treat patients with proven techniques and ground-breaking therapies.
The mesothelioma program combines the expertise of internationally recognized medical, surgical, pulmonary, and radiation experts. This multidisciplinary team uses a collaborative approach to offer the most advanced treatment, surgical techniques, and clinical trials available.
Conditions treated by the ACC include:
Though the center primarily treats pleural mesothelioma, the team in its mesothelioma program has the expertise and technology needed to treat peritoneal and pericardial mesothelioma as well.
The mesothelioma doctors at the Abramson Cancer Center are nationally recognized as experts in diagnosing and treating the disease. These highly trained specialists on the multidisciplinary care team make the ACC’s Mesothelioma and Pleural Disease Program stand out.
“We are consistently recognized nationally and internationally for excellence in health care. The cornerstone of our reputation is our medical and support staff, who choose to dedicate their careers to serving the needs of our patients and community.”
—Abramson Cancer Center
The ACC’s mesothelioma program is made up of:
Use our Free Doctor Match service for help connecting with a mesothelioma doctor who’s right for you.
The Abramson Cancer Center offers a wide range of mesothelioma treatment options. The highly skilled physicians at the ACC work with each patient to create the best treatment plan. Factors that are considered include the stage and location of mesothelioma and the age and general health of the patient.
The Abramson Cancer Center’s Mesothelioma and Pleural Disease Program offers more treatment options for mesothelioma and pleural disease than most medical centers worldwide.
Being able to offer such extensive treatment options is due to the ACC’s diverse team of professionals across a range of fields, its advanced use of research and technology, and its people-first approach to healing.
Treatments and services offered include:
As one of the top mesothelioma facilities in the nation, the Abramson Cancer Center offers the latest treatment methods to patients.
The Abramson Cancer Center has thoracic oncology surgeons with expertise in removing cancers in or around the lungs, including pleural mesothelioma. The ACC is also equipped to perform mesothelioma surgery on patients with other types of the disease.
Surgical options for mesothelioma may include:
Other treatments, such as chemotherapy or radiation therapy, are often combined with surgery. A combination of treatments helps to ensure as much of the cancer is removed as possible.
The Department of Radiation Oncology at the ACC is committed to its mission of “Excellence is Standard.” It is one of the most comprehensive radiation oncology programs in the world, offering patients nearly every radiation treatment option available.
The ACC performs radiation oncology at the Ruth and Raymond Perelman Center for Advanced Medicine and seven community-based locations.
Radiation therapy offered at the ACC includes:
The ACC also offers photodynamic therapy, which was brought to the center by Dr. Joseph Friedberg, who founded the Mesothelioma and Pleural Disease Program.
Photodynamic therapy uses low-level beams of light to target cancer cells. Mesothelioma patients undergoing the treatment will take a light-sensitive medication before surgery.
Once the visible tumors and cancer are removed, a light source is applied to the treatment area. It then interacts with the light-sensitive medication to create a cancer-killing chemical that destroys microscopic cancer cells.
The medical oncologists at the Abramson Cancer Center have ample experience using chemotherapy for mesothelioma to treat patients. The ACC develops and administers chemotherapy through an IV, pill, or liquid.
Chemotherapy can be highly effective for treating mesothelioma, especially when combined with other therapies.
The Abramson Cancer Center also offers immunotherapy for mesothelioma. Immunotherapy uses synthetic or biological agents to boost the body’s immune system and eliminate cancer cells.
For example, chimeric antigen receptor (CAR)-T cell therapy is used at the ACC. This is one of the newest and most promising immunotherapy treatments that Penn Medicine helped pioneer.
“The ACC is an international leader in cancer immunotherapy, pioneering the breakthrough of chimeric antigen receptor (CAR) T-cell therapy.”
—National Cancer Institute (NCI)
CAR T-cell therapy was first approved by the FDA in 2017 to treat certain forms of cancer. The groundbreaking therapy is currently being tested in clinical trials for mesothelioma patients.
The Abramson Cancer Center continuously conducts mesothelioma clinical trials for patients with various stages of mesothelioma. Ongoing cancer research and clinical trials aim to improve treatment options and survival rates.
The ACC regularly conducts almost 600 clinical trials with over 9,000 participants.
Highlights of its mesothelioma research program include:
Each clinical trial and research program at the ACC is meant to further the world’s understanding of cancer and the ability to treat it more effectively. Significant progress towards a mesothelioma cure has been made over the past few decades, and the ACC continues working towards that goal.
“Cumulatively, members of the ACC have led or co-led studies that resulted in multiple FDA approvals of cancer therapies ranging from immunotherapy to targeted therapy to robotic surgery.”
—National Cancer Institute (NCI)
While the ACC has ongoing mesothelioma clinical trials, it is important to understand that they are only a good fit for some patients. Talk with your doctor if you want to participate in a mesothelioma clinical trial.
Download our helpful list of questions to ask your doctor for the necessary information.
Penn Medicine and the Abramson Cancer Center accept most commercial health insurance plans.
Medicare Advantage, Pennsylvania Medical Assistance Managed Care (Medicaid), Community HealthChoices (CHC), and Affordable Care Act (ACA) Exchange are also accepted.
Insurance plans accepted at Abramson Cancer Center include:
Plans and coverage options for patients occasionally change as the hospital strives to work with insurance providers to treat as many people as possible. Contact your insurance carrier for the most up-to-date information on accepted insurance plans.
The Mesothelioma and Pleural Disease Program at the ACC is one of the best mesothelioma programs in the world for many reasons. It has nationally recognized experts on staff, offers more treatment options than most other medical facilities, and conducts cutting-edge research.
You can request an appointment online if you want to seek treatment at the ACC. You can also get dedicated assistance from Mesothelioma Hope.
Our Patient Advocates can review your diagnosis, answer your questions, and help match you with mesothelioma cancer centers that best meet your treatment goals.
Mesothelioma Hope has no affiliation with and is not endorsed or sponsored by Abramson Cancer Center. Any contact information listed is for informational purposes only. You have the right to contact Abramson Cancer Center directly.
Mesothelioma Hope is passionate about helping patients and families affected by this aggressive cancer. A mesothelioma diagnosis can be scary and isolating, but we’re here for you at every step. Hope is only a phone call away.
(866) 608-8933